JBF

3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid


Toggle HydrogenToggle Labels

Chemical Component Summary

Name3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
Identifiers3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
FormulaC15 H9 F N2 O3
Molecular Weight284.242
TypeNON-POLYMER
Isomeric SMILESc1ccc(c(c1)c2nc(no2)c3cccc(c3)C(=O)O)F
InChIInChI=1S/C15H9FN2O3/c16-12-7-2-1-6-11(12)14-17-13(18-21-14)9-4-3-5-10(8-9)15(19)20/h1-8H,(H,19,20)
InChIKeyOOUGLTULBSNHNF-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Bond Count32
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB05016 
NameAtaluren
Groups
  • approved
  • investigational
DescriptionAtaluren is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk. More specifically, ataluren is used in the small group of patients whose disease is caused by a specific genetic defect (called a ‘nonsense mutation’) in the dystrophin gene. This drug does not yet have approval by the US Food and Drug Administration or by Health Canada for any indications.
Synonyms
  • 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
  • Ataluren
Brand NamesTranslarna
IndicationAtaluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk. More specifically, ataluren is used in the small group of patients whose disease is caused by a specific genetic defect (called a ‘nonsense mutation’) in the dystrophin gene.
Categories
  • Musculo-Skeletal System
  • OAT1/SLC22A6 inhibitors
  • OAT3/SLC22A8 Inhibitors
  • OATP1B3 inhibitors
  • Oxazoles
ATC-CodeM09AX03
CAS number775304-57-9

Drug Targets

NameTarget SequencePharmacological ActionActions
UDP-glucuronosyltransferase 1-9MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL...unknownsubstrate
Solute carrier family 22 member 6MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...unknowninhibitor
Solute carrier family 22 member 8MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...unknowninhibitor
Solute carrier organic anion transporter family member 1B3MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKI...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 11219835
ChEMBL CHEMBL256997
ChEBI CHEBI:94805
CCDC/CSD IWOCON